© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad

More articles/Ad

More articles

  • SSA
    The European Commission has published proposals for allocating €87.3bn of its €100bn unemployment support programme SURE, the temporary Support to mitigate Unemployment Risks in an Emergency facility. Italy and Spain are set to receive the largest amounts.
  • A staggering amount of capital has been raised by the world’s airlines so far this year as the industry has suffered its worst crisis since 9/11 as a result of the Covid-19 pandemic.
  • French equity capital markets are having another subdued year. Just €8.77bn has been raised so far across IPOs, block trades, rights issues and convertible bonds, according to Dealogic data.
  • ABN Amro has become the 18th bank to call an additional tier one (AT1) in 2020, as refinancing conditions continue to improve, despite the impact of the coronavirus pandemic.
  • Chinese electric vehicle manufacturer XPeng has hit the road with its $1.1bn New York Stock Exchange IPO. It is the latest in a building pipeline of US listings by Mainland-based companies that are undeterred by rising tensions between the two countries.
  • A senior JP Morgan banker and head of its China securities joint venture has decided to leave his banking career for a job with a Hong Kong-listed Chinese drugmaker.